These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1319092)

  • 21. Saturnine gout, redux: a review.
    Dalvi SR; Pillinger MH
    Am J Med; 2013 May; 126(5):450.e1-8. PubMed ID: 23510947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of the CaNa2 EDTA Pb-mobilization test to detect occult lead nephropathy.
    Wedeen RP
    Uremia Invest; 1985-1986; 9(2):127-30. PubMed ID: 3939486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental model of lead nephropathy. I. Continuous high-dose lead administration.
    Khalil-Manesh F; Gonick HC; Cohen AH; Alinovi R; Bergamaschi E; Mutti A; Rosen VJ
    Kidney Int; 1992 May; 41(5):1192-203. PubMed ID: 1614034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of lead on the kidney: roles of high-affinity lead-binding proteins.
    Fowler BA; DuVal G
    Environ Health Perspect; 1991 Feb; 91():77-80. PubMed ID: 1710180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of L-arginine in hypertension and nephrotoxicity.
    Klahr S
    Curr Opin Nephrol Hypertens; 1998 Sep; 7(5):547-50. PubMed ID: 9818202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats.
    Liu J; Habeebu SS; Liu Y; Klaassen CD
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):48-58. PubMed ID: 9875299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chronic lead poisoning: Lead gout with giant tophi on the skin, nephrophathy and porphyrinopathy].
    Orfanos CE; Künzig M
    Hautarzt; 1975 Nov; 26(11):581-4. PubMed ID: 812845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proximal tubular nephropathy in two dogs diagnosed with lead toxicity.
    King JB
    Aust Vet J; 2016 Aug; 94(8):280-4. PubMed ID: 27461352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Early tubular involvements in lead poisoning in children].
    Gourrier E; Lamour C; Feldmann D; Bensman A
    Arch Fr Pediatr; 1991 Dec; 48(10):685-9. PubMed ID: 1793342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Secondary nephropathies in occupational health practice. I. Secondary nephropathies due to occupational exposure].
    Antonowicz-Juchniewicz J; Jodkowska A; Kwiecińiska D
    Med Pr; 2006; 57(4):389-400. PubMed ID: 17133921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Saturnine gout: a review of 42 patients.
    Halla JT; Ball GV
    Semin Arthritis Rheum; 1982 Feb; 11(3):307-14. PubMed ID: 6821383
    [No Abstract]   [Full Text] [Related]  

  • 32. Cell proliferation in rat kidneys after prolonged treatment with lead.
    Choie DD; Richter GW
    Am J Pathol; 1972 Aug; 68(2):359-70. PubMed ID: 4340334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic lead nephropathy.
    Emmerson BT
    Kidney Int; 1973 Jul; 4(1):1-5. PubMed ID: 4353288
    [No Abstract]   [Full Text] [Related]  

  • 34. Chronic lead accumulation as a possible cause of renal failure in gouty patients.
    Colleoni N; D'Amico G
    Nephron; 1986; 44(1):32-5. PubMed ID: 3092121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular basis of cadmium toxicity.
    Nath R; Prasad R; Palinal VK; Chopra RK
    Prog Food Nutr Sci; 1984; 8(1-2):109-63. PubMed ID: 6385135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of lead in gout nephropathy.
    Batuman V; Maesaka JK; Haddad B; Tepper E; Landy E; Wedeen RP
    N Engl J Med; 1981 Feb; 304(9):520-3. PubMed ID: 6779160
    [No Abstract]   [Full Text] [Related]  

  • 37. Bone lead, hypertension, and lead nephropathy.
    Wedeen RP
    Environ Health Perspect; 1988 Jun; 78():57-60. PubMed ID: 3203647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of kidney cell injury from metals.
    Fowler BA
    Environ Health Perspect; 1993 Apr; 100():57-63. PubMed ID: 8354182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lead Nephropathy.
    Ritz E; Wiecek A; Stoeppler M
    Contrib Nephrol; 1987; 55():185-91. PubMed ID: 3549150
    [No Abstract]   [Full Text] [Related]  

  • 40. Hyperkalemia and acidosis in lead nephropathy.
    Morgan JM
    South Med J; 1976 Jul; 69(7):881-3,6. PubMed ID: 941056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.